There is evidence that cell mediated immune mechanisms play a role in the pathogenesis of mucosal damage in coeliac disease and it is suggested that deranged immune response to gliadin occurs in these patients.' This suggestion also seems supported by analogies with animal models. 2 An altered distribution of the major histocompatibility complex class II epithelial cells.9 The second piece was immediately snap frozen in liquid nitrogen. The remaining piece was placed on a stainless steel mesh, positioned over the central well of an organ culture dish (Falcon, USA) with the villous surface of the biopsies uppermost. The well was then filled with culture medium at 37°C so as just to reach the cut surface of the biopsies. Ten millilitres of culture medium consisted of Trowell's T8 medium (6 5 ml), NCTC 135 medium (2 ml), fetal calf serum (15 ml), penicillin 50000 IU and streptomycin in 5000 IU. The dishes were placed in a sterile anaerobic jar which was gassed with 95% oxygen/ 5% carbon dioxide for 30 minutes before being sealed and incubated at 37°C. Biopsies were incubated in medium with or without the addition of a peptic tryptic digest of wheat gliadin at the final concentration of 0 1 mg/ml. The 
HLA-DR EXPRESSION IN BIOPSY SPECIMENS BEFORE CULTURE
Jejunal biopsies from controls and treated coeliac patients showed a normal mucosal histology. In all cases intraepithelial lymphocytes counts were below 40/100 epithelial cells (range 16-39). When specimens were stained with the anti-HLA-DR antibody, the villous epithelium was heavily stained and the maximal fluorescence was detected at the top of the villi. The staining appeared to decrease at the bottom of the villi and was absent in the crypts. The fluorescence was more intense in the subapical and basolateral regions of the enterocytes.
HLA-DR EXPRESSION IN BIOPSIES AFTER CULTURE
When biopsy specimens were cultured in medium without gliadin peptides the pattern of epithelial HLA-DR distribution was similar to that observed before the culture (Table) (Fig 1) . When the biopsies of treated coeliac patients were cultured in the presence ofgliadin peptides, in eight of 14 specimens an increased HLA-DR expression was found in the crypt epithelium Occurrence ofHLA-DR on the villous and crypt epithelium of jejunal biopsies cultured with or without gliadin peptides ( Fig 2) . In 11 of 14 biopsy specimens, after culture, the expression of HLA-DR in the villous epithelium was markedly reduced or even absent (Fig 3) .
Neither the enhanced HLA-DR expression in crypt cells, or its disappearance from villous surface was observed in eight biopsies from treated coeliacs cultured in the presence of maize peptides (Table) . No change in the HLA-DR epithelial expression was observed in control specimens cultured in the presence of gliadin peptides (Table) .
Discussion
The organ culture of human small intestine has been proposed as an in vitro model of coeliac disease. In most studies, biopsy specimens from patients on a gluten containing diet have been used. Such specimens showed morphologic and biochemical improvement when cultured in a medium free of gliadin, while no improvement was shown when gliadin was present in the culture medium." On the contrary, the mucosal morphology of biopsies from coeliac disease on a gluten free diet was not affected by the presence of gliadin in the culture medium. 12 In the present study we have used cultures of treated coeliac disease mucosa to determine whether changes in the DR epithelial expression could be induced by gliadin even in the absence of obvious mucosal damage.
We did not observe changes in the mucosal histology of specimens from treated coeliacs cultured in the presence of gliadin peptides. Nevertheless, the exposure to gliadin caused changes in the pattern of DR epithelial distribution reproducing the changes found 'in vivo' in untreated coeliac disease. These changes consisted of an enhanced DR expression by the crypt epithelium and a reduced or absent DR expression by the villous epithelium. The induction of these changes was restricted to mucosal samples of treated coeliacs. The induction of DR in the crypts and loss of epithelial DR from the villi may have different explanations.
As in vivo challenge makes the small intestine sensitive to the in vitro damaging effect of gliadin peptides,"I it could be suggested that the biopsies in which DR was induced in the crypts were those from patients in whom the reaction had already been triggered in vivo by small amounts ofgluten in the diet. This would not be supported by our finding of a normal mucosal histology and of normal preculture intraepithelial lymphocytes counts in all samples. The relation between the mucosal T cell activation and the changes in the epithelial DR expression is poorly understood. In animal models class II negative epithelial cells have been induced to express DR when cultured with supernatants of ConA stimulated spleen cells or intraepithelial lymphocytes,'3 and in man there is indirect evidence that intraepithelial 
